Table of Content



1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary
3.1. Snippet by Product
3.2. Snippet by Wound Type
3.3. Snippet by End-User

4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising prevalence of chronic wounds
4.1.2. Restraints
4.1.2.1. Lack of supportive reimbursement policies
4.1.3. Opportunity
4.1.4. Impact Analysis

5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product
7.2. Exudate Management *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.2.3. Hydrogel
7.2.4. Foam
7.2.5. Silicone Dressing
7.2.5.1. Silicone Lite Foam Dressing
7.2.5.2. Silicone absorbent dressings
7.2.5.3. Silicone gel sheets
7.2.6. Hydrocolloids
7.2.7. Alginate
7.2.8. Super Absorbent
7.3. Infection Management
7.3.1. Silver Wound Dressing
7.3.2. Collagen Dressing
7.3.3. Non-Silver Dressing
7.4. Therapy Devices
7.4.1. Negative Pressure Wound Therapies (NPWT Devices)
7.4.1.1. Conventional Negative Pressure Wound Therapy (NPWT)
7.4.1.1.1. Pumps
7.4.1.1.2. Canisters
7.4.1.1.3. Dressing Kits
7.4.1.2. Single-Use Negative Pressure Wound Therapy (NPWT)
7.4.1.3. Hyperbaric Oxygen Therapy
7.4.2. Ultrasonic Mist and Electrical Stimulation Devices
7.5. Compression Bandage
7.5.1. Full Compression – 2 layer
7.5.2. Others
7.6. Hemostatic Dressing
7.7. Nanofibre Dressing

8. By Wound Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
8.1.2. Market Attractiveness Index, By Wound Type
8.2. Chronic Wounds *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Acute Wounds
8.4. Pressure Ulcers
8.5. Venous Leg Ulcer
8.6. Diabetic Foot Ulcer

9. By End-User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Clinics
9.4. Ambulatory Surgical Devices
9.5. Community Health Service Centers
9.6. Homecare

10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles
11.1. Exciton Technologies Inc. *
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. Medtronic Plc
11.3. Philips Healthcare
11.4. ConvaTec, Inc.
11.5. Molnlycke Healthcare
11.6. Medline Industries, Inc.
11.7. Derma Sciences, Inc.
11.8. Smith & Nephew Inc.
11.9. Covalon Technologies Ltd.
11.10. B. Braun Melsungen AG
LIST NOT EXHAUSTIVE

12. Appendix
12.1. About Us and Services
12.2. Contact Us